INTERNATIONAL UROLOGY AND NEPHROLOGY, vol.41, no.1, pp.145-152, 2009 (SCI-Expanded)
Mycophenolate mofetil (MMF) has shown to be a reliable choice in the treatment of glomerulonephritis. We retrospectively reviewed the clinical course and response to MMF therapy in 49 patients with primary glomerulopathy (37 patients) and lupus nephritis [class III (five patients) and IV (seven patients)].